Lv1
30 积分 2024-09-06 加入
Curbing the Obesity Epidemic: Should GLP-1 Receptor Agonists Be the Standard of Care for Obesity?
2个月前
已完结
GLP-1 Receptor Agonists in Pediatric and Adolescent Obesity
2个月前
已完结
Irisin alleviates LPS-induced liver injury and inflammation through inhibition of NLRP3 inflammasome and NF-κB signaling
2个月前
已完结
Irisin reduces inflammatory signaling pathways in inflammation-mediated metabolic syndrome
2个月前
已完结
Irisin ameliorates high glucose‐induced cardiomyocytes injury via AMPK/mTOR signal pathway
2个月前
已完结
The effect of nutrition and exercise training on irisin and semaphorin-3E levels in obese patients
2个月前
已完结
The role of irisin in exercise-induced muscle and metabolic health: a narrative review
3个月前
已完结
Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC‐1
3个月前
已完结
Glucagon‐like peptide‐1 receptor agonist treatment associated weight fluctuation and influencing factors in patients with overweight or obesity
4个月前
已完结
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
5个月前
已完结
皖公网安备34019202002308
